Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
Collaborating Across APAC at BIO Asia–Taiwan to Advance High‑Quality Cross‑Border Clinical Research Harvest Integrated Research…
Collaborating Across APAC at BIO Asia–Taiwan to Advance High‑Quality Cross‑Border Clinical Research Harvest Integrated Research…